JAMA Editors' Summary

Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

06.16.2020 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 16, 2020 issue

More episodes from JAMA Editors' Summary